Patent ID: 6436922
Filing Date: 2002-08-20
Classification: A61P,C07D

Abstract:
A method for treating or preventing an irritable bowel syndrome, which comprises administering an effective amount of a pharmaceutical composition, wherein said pharmaceutical composition comprises a 5,11-dihydrodibenzo[b,e][1,4]oxazepine compound represented by formula (I), a stereoisiomer thereof, a pharmacologically acceptable salt thereof, or a hydrate thereof as an active ingredient: wherein R1 and R2 are the same or different and each represents a hydrogen atom, a halogen atom, a cyano group, a hydroxy group or a lower alkoxy group, or R1 and R2 together form â€”O(CH2)nOâ€” in which n is 1, 2 or 3, R3 represents a hydrogen atom or hydroxy group, R4 and R5 are the same or different and each represents a hydrogen atom or hydroxy group, or R4 and R5 together form &boxH;O group.